SUMMARY
The cloning of genes expressing proteins that are differentially expressed in the organ microvasculature has the potential to address a variety of problems ranging from the analysis of disease pathogenesis to drug targeting for particular tissues. This study describes a methodology designed to analyze differential protein expression in the brain microvasculature. The method can be applied to other organs, and is particularly suited to the cloning of cDNAs encoding membrane proteins. The technology merges a tissuespecific polyclonal antiserum with a cDNA library expression cloning system. The tissue-specific antiserum is subtracted with protein extracts from control tissues to remove those antibodies that recognize common antigenic proteins. Then, the depleted antiserum is used to expression clone tissue-specific proteins from a cDNA library expressed in mammalian cells. The methodology was evaluated with a rabbit polyclonal antiserum prepared against purified bovine brain capillaries. The antiserum was absorbed with acetone powders of liver and kidney and then used to screen a bovine brain capillary cDNA library in COS cells. The initial clone detected with this expression methodology
INTRODUCTION
The identification of proteins that are differentially expressed between tissues is critical to the illumination of mechanisms involved in both tissue development and tissue differentiation. Elucidation of differentially expressed proteins also has the potential to identify proteins that participate in the pathogenesis of diseases such as angiogenesis, aberrant proliferation, and altered cellular behavior. In addition, transport systems that are unique to a certain tissue or cell type could lead to novel targets for drug transport to specific tissue sites. Tissue-specific channels, endocytosing systems, and cellular receptors could function as such targets and mediate cell and organ-specific uptake.
Tissue specific gene expression can be evaluated with functional genomics that focuses on the detection of tissue-specific mRNAs. However, the correlation between the protein and mRNA contents of the cell is not necessarily linear since these levels are dynamic species regulated by distinct factors (1) . An example of this regulation can be seen in the 3'-untranslated regions of mRNA where regulatory proteins can bind and play a role in determining the post-transcriptional regulation of gene expression (2) .
Technologies used to analyze the protein content of cells include traditional expression cloning methods where a known target is extracted from a cDNA library (3,4) with a specific antibody. However, without a priori knowledge of a specific target, and without the availability of a specific antibody directed against the protein target, this method is limited. Other larger scale differential protein expression analyses include 2-dimensional gel electrophoresis (5,6) and subtractive expression cloning using phage display (7). difficult to analyze membrane proteins because of solubility constraints (5) . The method of coupling phage display of a cDNA library and a tissue-specific polyclonal antiserum can identify differentially expressed proteins (7), but is potentially limited by host biology and the rudimentary prokaryotic post-translational machinery (8) . This may be especially exacerbated in the case of library constituents that encode mammalian membrane proteins, which require proper folding in order to be antigenic on the surface of the phage particle (8, 9) .
In the present study, a robust proteomics technology was developed that allows the identification of tissue-specific proteins, including membrane proteins. The methodology is initially applied to the brain microvasculature, which forms the bloodbrain barrier (BBB) in vivo. A polyclonal antiserum against bovine brain microvessel endothelial proteins was depleted with protein preparations from liver and kidney tissues, which removes the antigenicity to commonly expressed proteins (10) . This depleted or subtracted antiserum was then used to screen a bovine brain capillary cDNA library in COS cells to identify proteins that were differentially expressed at the brain microvasculature, as compared to liver and kidney. The technique was validated with the cloning of the Lutheran membrane glycoprotein, which is a brain vascular-enriched protein. The method has the potential to identify molecular transporters for non-invasive drug delivery to the brain and can be applied to many other tissue types and systems.
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EXPERIMENTAL PROCEDURES
Bovine Brain Capillary cDNA Library Construction. Bovine brain microvessels were isolated from total bovine brain homogenates, and the brain capillary-derived mRNA was purified as previously described (11) . The integrity of the capillary mRNA was confirmed by actin Northern blot analysis (11) . Full-length cDNA inserts were created using the Superscript system (Invitrogen-Life Technologies, San Diego, CA). The mRNA was reverse transcribed using the NotI Oligo-dT primer adaptor and the 5' ends of the cDNA inserts were ligated to BstXI adaptors (Invitrogen) to allow directional cloning into the pcDNA1. PBS containing 1 mg/mL bovine serum albumin and adsorbed with rat kidney acetone powder at 37 °C for 1 hour, as described previously (10) . After pelleting the kidney acetone powder, the antiserum was adsorbed with rat liver acetone powder for 1 hour at 37 °C. The subtracted antiserum was then diluted further to 1:1000 and adsorbed with (12) . Positively stained cells were added to 300 µL Hirt extraction buffer (100 mM EDTA, 10 mM Tris pH 8.0, 0.1% SDS, 100 µg/mL proteinase K). After mixing the cells and Hirt buffer, the mixture was incubated overnight at 55 °C.
The mixture was centrifuged at 14000 rpm for 2 minutes to pellet any debris. The plasmid DNA was carefully extracted twice using 1 volume of phenol:chloroform (1:1).
Yeast tRNA (10 µg), 1/10 volume of 3M sodium acetate, and 2.5 volumes of 20 °C ethanol were added to the extracted aqueous phase to precipitate the DNA and centrifuged at 14000 for 20 minutes. After washing with 0.5 mL 70% ethanol, the DNA pellet was dried at room temperature for 10 minutes and re-suspended in 5 µL of 10 mM In vitro transcription translation reactions were carried out using the TNT rabbit reticulocyte system under the T7 promoter (Promega). The reactions were carried out with bovine Lutheran plasmid template both in the absence and presence of canine microsomal membranes. The 35 S-methionine reaction products were resolved on an SDS-PAGE gel, dried, and exposed to film. 
RESULTS
Pure preparations of bovine brain capillaries comprising the BBB were isolated from total brain homogenates, and were free of brain cells as shown by light microscopy ( Figure 1A ). Messenger RNA was purified from the microvessel preparation using oligo-dT cellulose and the integrity of the mRNA was analyzed by Northern blotting with an actin probe. As Figure 2A demonstrates, full-length mRNA was present and two mRNA species were observed in the microvessel mRNA preparation. The band at 2.1 kb corresponds to beta and gamma actin; whereas the 1.6 kb band originates from the alpha actin component of the smooth muscle cells that line portions of the brain endothelium. when transfections were performed with the DEAE dextran method. Lipofectamine transfections yielded higher transfection efficiencies but did not result in enrichment of the alpha actin cDNA, and bacterial pools following extraction and re-transfection were 10 times larger. This is presumably because increased cellular uptake of plasmid or nonspecific cell-associated plasmid is recovered in the extraction process and masks the truly positive clones. This did not appear to be a problem when DEAE dextran was used.
In order to identify those proteins that elicit the Western blot ( Figure 3A ) and intact capillary ( Figure 1C ) staining, a modified expression cloning procedure was developed. In this procedure, the differential protein expression derived from the BBB cDNA library was evaluated using the BBB-specific subtracted antiserum (Figure 1 Figure 4A , and 13 potential positives cells were extracted from the plate, the plasmid DNA recovered, and re-transfected into COS-1 cells. After repeating the immunocytochemistry with the BBB-specific antiserum, a 33-fold enrichment was observed and a representative field is shown in Figure 4B . At this point, positive clones were again isolated and the process repeated to yield a highly enriched pool of 150 clones ( Figure 4C and Figure 1D ). Plasmid DNA from 36 of these clones was transfected into COS-1 cells and 3 clones that resulted in positive staining with the BBB-specific polyclonal antibody were identified ( Figure 4D ). These clones did not react with the preimmune antiserum ( Figure 4E ) and represented clones that were reactive only with the BBB-specific antibody mixture. Only three rounds of enrichment were necessary to clone this protein whose cDNA is estimated to be present at a frequency of 1 in 5000 in the bovine cDNA library. 
